Centrus Energy (LEU) Q3 2026 Earnings Call Transcript

Centrus Energy's Q3 2026 revenue fell 26% year over year to $55.5 million, and adjusted net loss was $9.4 million versus adjusted net income of $5.2 million a year earlier; a $46.4 million non-cash warrant-liability gain lifted GAAP net income to $31.6 million. The company reaffirmed 2026 revenue guidance of $450 million–$500 million and capital-spend guidance of $350 million–$500 million, while reporting a $7 billion total backlog, including $5.4 billion in contingent enrichment commitments. Centrus reported $2.2 billion in unrestricted cash after a $500 million offering and completed its first Oak Ridge centrifuge ahead of schedule, but noted that the proposed FY2027 U.S. budget excludes further funding for the HALEU operations contract, representing about $0.8 billion of Technical Solutions backlog.

Analysis

LEU’s central risk is a cash-and-margin conversion gap: long-dated backlog and supplier readiness have value only if centrifuge output scales while unit costs fall. The 28% increase in SWU unit costs alongside a larger normalized operating loss suggests ramp economics—not demand visibility—are the near-term underwriting test. Delivery timing can explain a weak quarter, but it does not explain away the cost trajectory. The $7B headline backlog should not be capitalized like revenue; verify firm delivery schedules, cancellation/contingency terms, prepayment coverage and contract-level economics.

The FY2027 budget omission for the HALEU operations contract puts roughly $0.8B of Technical Solutions backlog at risk of delay or renegotiation, even if other federal support persists. That creates a second-order risk: slower government-funded work could compete for management attention and capacity with commercial commitments. Westermann may reduce supply-chain bottlenecks, but claimed accretion and savings remain unverified until segment contribution and integration costs are disclosed. Palantir’s role is not yet a separately demonstrated earnings driver.

Near term, expect volatility around the December 7 Investor Day and any federal funding clarification. Over 1–3 months, focus on production cadence, capital-spend trajectory and whether SWU costs stabilize. Over 6–18 months, successful scaling could strengthen domestic-enrichment pricing power; failure to ramp would expose the equity to high execution risk. The raise improves funding runway, but warrants create potential dilution and an overhang if the share price trades above exercise levels. Contrarian point: supply scarcity is supportive, but backlog growth and a first completed centrifuge are milestones, not proof of profitable capacity. No valuation or share-price context is supplied, so avoid a directional trade based on this call alone.

Key Decisions for Investors

• Keep LEU on a catalyst watchlist rather than chase the operational milestone; reassess after the December 7 Investor Day, requiring disclosed unit cadence, capacity milestones and 2027 capital-spend detail before underwriting the ramp.
• Treat LEU as neutral-to-underweight until SWU unit costs stabilize and gross margins improve. Falsify this caution if subsequent reporting shows sustained cost improvement alongside rising production, not merely delivery-driven revenue recovery.
• Track the FY2027 budget process and DOE contract amendments: funding clarity for the HALEU operations contract could remove a backlog-quality discount; continued omission or a material contract reset would strengthen the downside case.
• For PLTR, make no earnings attribution from this partnership announcement. Revisit only if Centrus or Palantir quantifies realized savings, timing and financial treatment; management’s stated opportunity is not verified PLTR revenue or profit.